141 related articles for article (PubMed ID: 22124007)
1. Methylene blue dye-related changes in the breast after sentinel lymph node localization.
Kang SS; Han BK; Ko EY; Shin JH; Cho EY; Lee JE; Nam SJ; Yang JH
J Ultrasound Med; 2011 Dec; 30(12):1711-21. PubMed ID: 22124007
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
Simmons RM; Smith SM; Osborne MP
Breast J; 2001; 7(3):181-3. PubMed ID: 11469932
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
Nour A
Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
7. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
8. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
9. SNOLL. Sentinel node and occult (impalpable) lesion localization in breast cancer.
Thind CR; Tan S; Desmond S; Harris O; Ramesh HS; Chagla L; Ray A; Audisio R
Clin Radiol; 2011 Sep; 66(9):833-9. PubMed ID: 21546007
[TBL] [Abstract][Full Text] [Related]
10. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
12. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
14. [Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
Bühler H S; Rojas P H; Cayazzo M D; Cunill C E; Vesperinas A G; Hamilton S J
Rev Med Chil; 2008 Aug; 136(8):1015-20. PubMed ID: 18949185
[TBL] [Abstract][Full Text] [Related]
15. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
[TBL] [Abstract][Full Text] [Related]
18. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping.
Blessing WD; Stolier AJ; Teng SC; Bolton JS; Fuhrman GM
Am J Surg; 2002 Oct; 184(4):341-5. PubMed ID: 12383897
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
[TBL] [Abstract][Full Text] [Related]
20. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]